Skip to content

Changes in left atrial function after respective treatments of paroxysmal atrial fibrillation with cryoballoon ablation, radiofrequency ablation under the guidance of three-dimensional mapping and cryoballoon ablation combined with three-dimensional mapping and effects of the application of statin drugs

Effects of different surgical methods for paroxysmal atrial fibrillation combined with the application of statin drugs on left atrial function

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-16007954
Enrollment
Unknown
Registered
2016-02-20
Start date
2016-03-01
Completion date
Unknown
Last updated
2018-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial fibrillation

Interventions

Cryoablation group:cryoballoon ablation
Cryoablation combined with 3D mapping group:ryoballoon ablation combined with 3D mapping
statin treatment group:orally receive 20 mg of atorvastatin per night (Pfizer) for three days before the operation and three months after the operation.

Sponsors

The Second Hospital of Hebei Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 80 Years

Inclusion criteria

Inclusion criteria: paroxysmal atrial fibrillation episode occurs in the patient at least twice within half a year (electrocardiogram data or Holter), atrial fibrillation cannot be prevented in patients who orally take class I and III antiarrhythmic drugs, and patient age is <80 years

Exclusion criteria

Exclusion criteria: patients with previous history of atrial fibrillation ablation, atrial thrombosis, or valvular heart disease (moderate and severe valvular stenosis, severe valvular regurgitation), LA >50 mm, patients who underwent prosthetic heart valve replacement, pregnant women, hyperlipidemia, patients with existing liver and kidney disease, malignant tumors or hematological system diseases

Design outcomes

Primary

MeasureTime frame
left atrial anterior and posterior diameter;mitral e ";E peak and A peak;left atrial ejection fraction;left atrial strain and left atrial strain rate;The LAA emptying velocity;biochemical parameters in detail (including all blood routine indicators [NE%, LY%, NE/LY], INR, enzymes, troponin, blood lipids and D-D dimer);the success rate of the operation;intraoperative complications;x????;the incidence of postoperative thrombosis;

Countries

China

Contacts

Public ContactXie ruiqin
13230178060@163.com+86 15830212537

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026